טוען...
Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application
Treatment of advanced lung cancer is one of the major challenges in current medicine because of the high morbidity and mortality of the disease. Advanced stage lung cancer is refractory to conventional therapies and has an extremely poor prognosis. Thus, new therapeutic approaches are needed. Lung t...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2006
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2203213/ https://ncbi.nlm.nih.gov/pubmed/17024232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.cgt.7700991 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|